公司資料
AstraZeneca PLC 股價、新聞與催化劑
- 股票代碼:
- AZN
- 交易所:
- NASDAQ
- 產業:
- Small Molecule Drugs, Biologics
- 所在地:
- UK
股票表現
166.14 USD (+2.00%)
收盤價
最後更新: 2026年9月17日
275B USD
市值
股價為何變動
截至 2026年9月17日，AZN 上漲 2.00%，收於 $166.14。目前新聞監測窗口內未發現新的同公司新聞。
公司概覽
業務概覽
AstraZeneca is a global biopharmaceutical company with deep exposure to oncology, cardiovascular, renal, metabolic disease, respiratory, and rare disease. The company has become one of the market’s strongest large-cap growth stories.
所在地與產業分類
Headquartered in the UK and listed on the U.S. as an ADR, AstraZeneca has a global operating footprint across major healthcare markets. It is a multinational biopharma with broad therapeutic reach.
商業模式特徵
AstraZeneca relies on blockbuster medicines, strong launch execution, and a pipeline that continues to refresh growth. Investors watch oncology momentum, pipeline readouts, and whether new launches can sustain the company’s growth profile.
生技產業定位
AstraZeneca sits near the top of the large-cap biotech/pharma landscape because it combines scale, growth, and strong R&D execution. It is less binary than smaller biotechs but still highly reactive to major oncology and pipeline news.
未來催化劑
- AstraZeneca’s watchlist should stay on camizestrant, datopotamab deruxtecan, and other late-stage oncology assets that can prove the company still has multiple shots on goal. The important part is whether the update changes the odds of the next milestone rather than just confirming the current story. If the event is positive, it can improve the market’s willingness to pay for the name ahead of the following catalyst.
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。